"病床数164床の総合病院です。 健診から専門的医療まで幅広く対応いたします。 診療科目：内科･血液内科･消化器内科･糖尿病内科･循環器内科･外科･乳腺外科･整形外科･小児科･麻酔科･リハビリテーション科。"

During the past decade, Aiiku Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aiiku Hospital" are "Acute Myeloid Leukemia" (1 trials), "Mature B-cell Malignancies" (1 trials) and "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)" (1 trials). Many other conditions were trialed in "Aiiku Hospital" in a lesser frequency.

Most popular intervention types in "Aiiku Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (1 trials), "Dexamethasone" (1 trials), "Imatinib" (1 trials), "Methotrexate" (1 trials) and "Oral Azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aiiku Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Aiiku Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Aiiku Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aiiku Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".